2′,3′-Dideoxyinosine Inhibits the Humoral Immune Response in Female B6C3F1 Mice by Targeting the B Lymphocyte

This publication has 16 references indexed in Scilit:

• Immunotoxicity of 2′,3′-Dideoxyinosine in Female B6C3F1 Mice
  Drug and Chemical Toxicology, 1997
• Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides
  Antimicrobial Agents and Chemotherapy, 1994
• Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection
  International Journal of Immunopharmacology, 1991
• The B lymphocyte is the immune cell target for 2′,3′-dideoxyadenosine
  Toxicology and Applied Pharmacology, 1990
• Overview of the Preclinical Development of an Antiretroviral Drug, 2′,3′-Dideoxyinosine
  Clinical Infectious Diseases, 1990
• Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex
  New England Journal of Medicine, 1990
• Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.
  Proceedings of the National Academy of Sciences, 1987
• IMMUNIZATION OF DISSOCIATED SPLEEN CELL CULTURES FROM NORMAL MICE
  The Journal of Experimental Medicine, 1967
• A Multiple Comparison Procedure for Comparing Several Treatments with a Control
  Journal of the American Statistical Association, 1955
• Sub-Sampling for Attributes
  Journal of the Royal Statistical Society Series B: Statistical Methodology, 1937